SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/01/16 Orthofix Medical Inc. 10-Q 6/30/16 56:5.6M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 488K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 11: R1 Document and Entity Information HTML 39K 12: R2 Condensed Consolidated Balance Sheets HTML 89K 13: R3 Condensed Consolidated Balance Sheets HTML 30K (Parenthetical) 14: R4 Condensed Consolidated Statements of Operations HTML 133K and Comprehensive Income (Loss) 15: R5 Condensed Consolidated Statements of Cash Flows HTML 62K 16: R6 Nature of operations, basis of presentation and HTML 32K recently issues accounting pronouncements 17: R7 Inventories HTML 46K 18: R8 Long-term debt HTML 23K 19: R9 Derivative instruments HTML 68K 20: R10 Fair value measurements HTML 180K 21: R11 Accumulated other comprehensive loss HTML 71K 22: R12 Earnings per share HTML 58K 23: R13 Share-based compensation HTML 26K 24: R14 Income taxes HTML 25K 25: R15 Business segment information HTML 207K 26: R16 Contingencies HTML 48K 27: R17 Share repurchase plan HTML 22K 28: R18 Nature of operations, basis of presentation and HTML 32K recently issues accounting pronouncements (Policies) 29: R19 Inventories (Tables) HTML 46K 30: R20 Derivative instruments (Tables) HTML 65K 31: R21 Fair value measurements (Tables) HTML 172K 32: R22 Accumulated other comprehensive loss (Tables) HTML 67K 33: R23 Earnings per share (Tables) HTML 55K 34: R24 Business segment information (Tables) HTML 203K 35: R25 Nature of operations, basis of presentation and HTML 21K recently issues accounting pronouncements - Additional Information (Detail) 36: R26 Inventories - Schedule of Inventories (Detail) HTML 31K 37: R27 Long-Term Debt - Additional Information (Detail) HTML 35K 38: R28 Derivative Instruments - Schedule of Fair Values HTML 28K of Derivative Instruments (Detail) 39: R29 Derivative Instruments - Schedule of Gain (Loss) HTML 25K Recognized in Other Comprehensive Income (Loss) (Detail) 40: R30 Fair Value Measurements - Schedule of Financial HTML 53K Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) 41: R31 Fair Value Measurements - Additional Information HTML 42K (Detail) 42: R32 Fair Value Measurements - Schedule of HTML 28K Reconciliation of Debt Securities (Detail) 43: R33 Accumulated Other Comprehensive Loss - Components HTML 46K of Changes in Accumulated Other Comprehensive Loss (Detail) 44: R34 Accumulated Other Comprehensive Loss - Components HTML 35K of Changes in Accumulated Other Comprehensive Loss (Parenthetical) (Detail) 45: R35 Earnings Per Share - Schedule of Reconciliation of HTML 29K Weighted Average Shares Used in Calculation of Basic and Diluted Net (Loss) Income Per Share (Detail) 46: R36 Earnings Per Share - Additional Information HTML 28K (Detail) 47: R37 Share-based Compensation - Additional Information HTML 31K (Detail) 48: R38 Income Taxes - Additional Information (Detail) HTML 27K 49: R39 Business Segment Information - Additional HTML 20K Information (Detail) 50: R40 Business Segment Information - Schedule of Net HTML 34K Sales by SBU Reporting Segment (Detail) 51: R41 Business Segment Information - Summary of Net HTML 53K Margin as Gross Profit Less Sales and Marketing Expense by SBU Reporting Segment (Detail) 52: R42 Contingencies - Additional Information (Detail) HTML 41K 53: R43 Share Repurchase Plan - Additional Information HTML 34K (Detail) 55: XML IDEA XML File -- Filing Summary XML 99K 54: EXCEL IDEA Workbook of Financial Reports XLSX 50K 5: EX-101.INS XBRL Instance -- ofix-20160630 XML 1.55M 7: EX-101.CAL XBRL Calculations -- ofix-20160630_cal XML 116K 8: EX-101.DEF XBRL Definitions -- ofix-20160630_def XML 272K 9: EX-101.LAB XBRL Labels -- ofix-20160630_lab XML 639K 10: EX-101.PRE XBRL Presentations -- ofix-20160630_pre XML 492K 6: EX-101.SCH XBRL Schema -- ofix-20160630 XSD 104K 56: ZIP XBRL Zipped Folder -- 0001564590-16-021905-xbrl Zip 94K
Exhibit 31.1
CERTIFICATION
I, Bradley R. Mason, certify that:
1. |
I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2016, of Orthofix International N.V.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b. |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
c. |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
d. |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has material affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
a. |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b. |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: August 1, 2016 |
By: |
|
/s/ BRADLEY R. MASON |
|
Name: |
|
|
|
Title: |
|
President and Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/1/16 | 8-K | ||
For Period end: | 6/30/16 | |||
List all Filings |